<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Compellent Technologies Inc.</title>
	<atom:link href="http://www.stockbloghub.com/tag/compellent-technologies-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(NVS) Novartis&#8217; Tasigna Trial for Gastrointestinal Stromal Tumor Halted</title>
		<link>http://www.stockbloghub.com/2011/04/13/nvs-novartis-tasigna-trial-for-gastrointestinal-stromal-tumor-halted/71382</link>
		<comments>http://www.stockbloghub.com/2011/04/13/nvs-novartis-tasigna-trial-for-gastrointestinal-stromal-tumor-halted/71382#comments</comments>
		<pubDate>Wed, 13 Apr 2011 21:19:33 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[Compellent Technologies Inc.]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[Novartis AG]]></category>
		<category><![CDATA[NVS]]></category>
		<category><![CDATA[ONXX]]></category>
		<category><![CDATA[Onyx Pharmaceuticals Inc]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>
		<category><![CDATA[Tenaris SA]]></category>
		<category><![CDATA[TS]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71382</guid>
		<description><![CDATA[Novartis (NVS) faced a pipeline setback recently as it announced discontinuation of a late-stage study (ENESTg1) of its drug Tasigna on the recommendation of an independent data monitoring committee. The study evaluated Tasigna versus Glivec as a first-line treatment for unresectableor metastatic GIST (gastrointestinal stromal tumor), a form of stomach cancer. Both Tasigna and Glivec are currently marketed by Novartis. Tasigna is marketed for the treatment of first and second line chronic myeloid leukemia (CML) and Glivec is marketed both for CML and adjuvant treatment of GIST. Glivec is considered the current standard of care for the treatment of GIST. The trial was stopped as interim data from the trial hinted that Tasigna was unlikely to show any superiority over Glivec. The primary endpoint of the trial was a comparison ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/13/nvs-novartis-tasigna-trial-for-gastrointestinal-stromal-tumor-halted/71382/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(DELL) Dell Completes Buyout of Compellent Technologies</title>
		<link>http://www.stockbloghub.com/2011/02/24/dell-dell-completes-buyout-of-compellent-technologies/67501</link>
		<comments>http://www.stockbloghub.com/2011/02/24/dell-dell-completes-buyout-of-compellent-technologies/67501#comments</comments>
		<pubDate>Thu, 24 Feb 2011 14:41:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[Compellent Technologies Inc.]]></category>
		<category><![CDATA[DELL]]></category>
		<category><![CDATA[Dell Inc.]]></category>
		<category><![CDATA[EMC]]></category>
		<category><![CDATA[EMC Corporation]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[HPQ]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=67501</guid>
		<description><![CDATA[Yesterday, Dell Inc. (DELL) announced that it has completed the acquisition of storage-solution provider Compellent Technologies Inc. (CML), after receiving shareholders’ approval at a special shareholder meeting. As consideration, Dell had to pay $27.75 per share for each Compellent share in cash. Dell expects the acquisition to be accretive to pro forma earnings in fiscal 2012. Data storage plays a crucial role in cloud computing, which helps users access remote computing power and data over the Internet. Founded in 2002, Compellent Technologies is a global provider of enterprise data storage systems, which facilitate the automation of data movement and management at the block or granular level. The company developed its flagship Storage Center software and hardware solution aimed at mid-size enterprises, selling it through an all-channel network of independent solution ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/24/dell-dell-completes-buyout-of-compellent-technologies/67501/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(NTAP) NetApp Announces Agreement to Acquire Akorri Networks</title>
		<link>http://www.stockbloghub.com/2011/02/02/ntap-netapp-announces-agreement-to-acquire-akorri-networks/65177</link>
		<comments>http://www.stockbloghub.com/2011/02/02/ntap-netapp-announces-agreement-to-acquire-akorri-networks/65177#comments</comments>
		<pubDate>Wed, 02 Feb 2011 15:09:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Data Storage Devices]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[Compellent Technologies Inc.]]></category>
		<category><![CDATA[DELL]]></category>
		<category><![CDATA[Dell Inc.]]></category>
		<category><![CDATA[EMC]]></category>
		<category><![CDATA[EMC Corporation]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[HPQ]]></category>
		<category><![CDATA[Isilon Systems Inc.]]></category>
		<category><![CDATA[ISLN]]></category>
		<category><![CDATA[NetApp Inc.]]></category>
		<category><![CDATA[NTAP]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65177</guid>
		<description><![CDATA[Storage and data management solutions provider NetApp Inc. (NTAP) sealed a definitive agreement to acquire Akorri Networks Inc. in an all-cash deal. The deal value has not yet been disclosed. NetApp expects the deal to be wrapped up by the end of its fourth quarter. Massachusetts-based Akorri Networks’ flagship BalancePoint software, which is used for capacity analytics, helps to analyze and virtualize data center operations, with a focus on managing and tracking storage capacity. The solutions enable customers to identify performance bottlenecks and improve storage capacity planning to free up time, people, and budget resources required for both physical and cloud environments. BalancePoint software supports virtual machines and networks, as well as storage-area networks (SANs). The latest version of this software provides predictive analysis for proactive management and troubleshooting. The ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/02/02/ntap-netapp-announces-agreement-to-acquire-akorri-networks/65177/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CML) Compellent Technologies &#8211; Earnings Estimates Are Still Rising</title>
		<link>http://www.stockbloghub.com/2009/12/22/cml-compellent-technologies-earnings-estimates-are-still-rising/23282</link>
		<comments>http://www.stockbloghub.com/2009/12/22/cml-compellent-technologies-earnings-estimates-are-still-rising/23282#comments</comments>
		<pubDate>Tue, 22 Dec 2009 18:53:46 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Data Storage Devices]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[CML]]></category>
		<category><![CDATA[Compellent Technologies Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23282</guid>
		<description><![CDATA[Compellent Technologies, Inc. (CML) estimates are rising, along with its share price, following recent news. Estimates Still Rising Since Compellent was featured as a Zacks Rank Buy in early November, full-year estimates have gained a penny for this and next year. The current Zacks Consensus Estimate is 16 cents for 2009 and 24 cents in 2010. Public Offering Compellent offered 3.8 million shares at a 2% discount to raise over $65 million in late November. Only 600,000 of the shares came from the company, the remainder was offered by shareholders. Shares rose sharply on the news. The Chart Shares of CML were volatile around the public offering, but have gained ground since being feature in November. The MACD is about the cross over, which is viewed as a bullish indicator. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/22/cml-compellent-technologies-earnings-estimates-are-still-rising/23282/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

